Electroencephalographic changes occurring during L-dopa treatment.
D000328:Adult; D000368:Aged; D001921:Brain / Q000503:physiopathology*; D002540:Cerebral Cortex / Q000503:physiopathology; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D013788:Thalamus / Q000601:surgery
D004295:Dihydroxyphenylalanine